Clinical trial · Interventional
An Individualised and Patient-centred Follow-up Program for Women With Gynaecological Cancer
A Randomised Clinical Trial Testing the Effect of an Individualised and Patient-centred Follow-up Program for Women With Gynaecological Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized controlled trial is testing the hypothesis that an individually focused and need-based nurse led follow-up program supported by electronic Patient Reported Outcome Measures for women with gynecological cancer will improve patient's empowerment, quality of life and involvement in the follow-up process besides reducing the patient's fear of cancer recurrence and degree of psychological distress, compared with a doctor led follow-up program. Further, nurse led follow-up by telephone, may reduce resources of the department as well as of the patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Empowerment, Cervical Cancer, Endometrial Cancer, Follow-up, Nurse-led, PROM | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| NEMO: NEw MOdel of follow-up | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- Standard follow-up in doctors setting
- interventionNames
- Behavioral: NEMO: NEw MOdel of follow-up
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Nurse-led follow-up with focus on empowerment and need assessment by use of ePROMS
- interventionNames
- Behavioral: NEMO: NEw MOdel of follow-up
Primary outcomes (1)
- measure
- Patient Empowerment using the Health Education Impact Questionnaire (HEI-Q)
- timeFrame
- Change from baseline (3 months post operative) to 12 months post operative.
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * No adjuvant therapy after surgery * Speak and write Danish * Mentally capable to adapt to intervention Exclusion Criteria: * Indication for adjuvant therapy after primary surgical treatment
References
Publications (1)
- DERIVEDBergholdt SH, Hansen DG, Johnsen AT, Boman BS, Jensen PT. A NEw MOdel of individualized and patient-centered follow-up for women with gynecological cancer (the NEMO study)-protocol and rationale of a randomized clinical trial. Trials. 2023 Feb 1;24(1):74. doi: 10.1186/s13063-022-07022-0. PMID 36726187